Ceribell has created a cloud-based, AI-enabled electroencephalography (EEG) headset which helps diagnose seizures without the presence of an EEG technologist or specialist interpreter, allowing for faster diagnosis and better treatment.
Though founded back in 2014, Ceribell experienced a huge breakthrough in 2022 when its system was granted FDA clearance to help diagnose suspected seizures, which has led to a boost in venture capital investment.
The company has also gone on to receive the FDA’s Breakthrough Device Designation for its ability to diagnose delirium, or acute brain failure and was placed on the World's Most Innovative COmpanies List 2023 by the Fast Company. Ceribell has no plans on stopping there though, and intends to grow its team rapidly in a bid to expand its tech capabilities for a range of other neurological conditions.
Steph
Company Specialist at Welcome to the Jungle